DGAT2 Antibodies

Santa Cruz Biotechnology provides a broad selection of DGAT2 Antibodies for research in lipid metabolism and energy homeostasis. DGAT2 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Diacylglycerol O-acyltransferase 2 (DGAT2) plays a crucial role in triglyceride synthesis and lipid droplet formation, making it an important target for studies related to obesity, diabetes, and metabolic disorders. Understanding DGAT2 function provides valuable insights into the regulation of lipid metabolism and its implications in various diseases. Research applications include investigating metabolic pathways, cellular signaling mechanisms, and potential therapeutic interventions. DGAT2 monoclonal antibodies enable precise detection and characterization of protein expression patterns across different tissue types and experimental conditions. Advanced labeling options include conjugates with horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) for enhanced detection flexibility. Santa Cruz Biotechnology monoclonal antibodies for DGAT2 support researchers worldwide in advancing our understanding of metabolic diseases and potential therapeutic strategies.